 Home > Medical News > Latest Medical News > Phase 3 clinical trial of TROP2 targeting ADC/blockbuster PD-1 antibody for the first-line treatment of lung cancer is about to start

Phase 3 clinical trial of TROP2 targeting ADC/blockbuster PD-1 antibody for the first-line treatment of lung cancer is about to start

 Last Update: 2021-11-02
 Source: Internet
 Author: User

Tags

non cyclic amp

iodine phase diagram

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On October 25, 2021, Daiichi Sankyo and AstraZeneca jointly announced that they have reached a clinical trial cooperation and supply agreement with a subsidiary of MSD

Lung cancer is the world's second most common cancer and the leading cause of cancer-related deaths, with 80%-85% of NSCLC

TROP2 is a transmembrane glycoprotein that is widely expressed in several types of solid tumors, including NSCLC

▲Introduction to Dato-DXd (DS-1062) (picture source: Daiichi Sankyo official website)

Keytruda improves the anti-cancer response of human immune cells by blocking the PD-1/PD-L1 signaling pathway

This collaboration is based on the positive results of a Phase 1b clinical trial reached in May 2020 last year

Reference materials:

[1] Second Clinical Trial Collaboration Initiated to Evaluate Datopotamab Deruxtecan in Combination with Keytruda® (pembrolizumab) in Patients with Metastatic Non-Small Cell Lung Cancer.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.